Objective: To formulate economic transdermal patch of lornoxicam (LX) and to study its anti-inflammatory activity on acute and chronic inflammatory in rat models Method: Three LX transdermal patches (F1, F2 and F3) consist of Eudragit RL-100 and RS-100 in three different ratios (1:2, 1:1 and 2:1) were prepared respectively by the solvent evaporation technique. All formulations contain diethylph...

Objective: The main objective of the present work is development polymeric low-density microballoons for prolonged gastroretentive delivery and optimization promising formulation by central composite design response surface methodology. Methods: Mebendazole-loaded were prepared emulsion solvent diffusion method using Eudragit S-100 hydroxypropyl methylcellulose as release controlling polymers. ...

SUMMARY A novel emulsification/solvent evaporation process was developed to formulate prednisoloneloaded Eudragit L and S microparticles as drug delivery vehicles to target different regions of the gastrointestinal tract. Microparticles were characterised in vitro and in vivo. This is the first report of drug absorption form orally administered Eudragit L and S microparticles. INTRODUCTION Dela...

The present study was designed to investigate the effect of different types of coating polymers such as Eudragit RL 30D, Eudragit RS 30D, Eudragit NE 30D, Surelease, and Kollicoat SR 30D on physical properties and release pattern of salbutamol sulphate (SS) pellets which were prepared by Extrusion-Spheronization technology. All the polymers used in coating solution were in aqueous dispersion fo...

The bioactive aqueous extract of Nigella sativa L. seed waste was formulated into soft gelatin capsules (Su1-Su6) in a dose of 200 mg/kg b. w. using different pharmaceutical excipients: soya lecithin/ span80/ sodium taurocholate, PEG 400, and Meglyol 810. The formulations were evaluated for their immunostimmulant and hepatoprotective activities using biochemical methods and for their release by...

The aim of the present study was to develop Exemestane loaded polymeric nanoparticles for improved oral bioavailability of Exemestane. Exemestane loaded nanoparticles were prepared by solvent displacement method with Eudragit RL 100 and Eudragit L 100 as polymers and Pluronic® F-68 as surfactant. The influence of various formulation factors (drug: polymer ratio and concentration of surfactant) ...

OBJECTIVES The aim of this study was to design and evaluate a chitosan-based film that has properties required for successful wound dressing, and can control drug penetration and maintenance time in the location. METHODS Several formulations of a film containing chitosan (3%) and different concentrations of Eudragit RL (0.5%, 1%, and 1.5%) were prepared using the casting/solvent evaporating t...

An ideal drug delivery system will possess three main properties: (a) It will be a single dose for the whole duration of treatment. (b) It will deliver the active drug directly at the site of action. (c) It will possess possible fewer side effects. Above approaches are achieved with the help of suitable choice of polymer. When it comes to targeted drug release profiles, Eudragit is the pharmace...